Compromising the 19S proteasome complex protects cells from reduced flux through the proteasome
Peter Tsvetkov,
Marc L Mendillo,
Jinghui Zhao,
Jan E Carette,
Parker H Merrill,
Domagoj Cikes,
Malini Varadarajan,
Ferdy R van Diemen,
Josef M Penninger,
Alfred L Goldberg,
Thijn R Brummelkamp,
Sandro Santagata,
Susan Lindquist
Affiliations
Peter Tsvetkov
Whitehead Institute for Biomedical Research, Cambridge, United States
Marc L Mendillo
Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, United States
Jinghui Zhao
Department of Cell Biology, Harvard Medical School, Boston, United States
Jan E Carette
Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States
Parker H Merrill
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, United States
Domagoj Cikes
Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria
Malini Varadarajan
Whitehead Institute for Biomedical Research, Cambridge, United States
Ferdy R van Diemen
Department of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands
Josef M Penninger
Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria
Alfred L Goldberg
Department of Cell Biology, Harvard Medical School, Boston, United States
Thijn R Brummelkamp
Department of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands
Sandro Santagata
Whitehead Institute for Biomedical Research, Cambridge, United States; Department of Pathology, Brigham and Women's Hospital, Boston, United States; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States
Susan Lindquist
Whitehead Institute for Biomedical Research, Cambridge, United States; Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, United States
Proteasomes are central regulators of protein homeostasis in eukaryotes. Proteasome function is vulnerable to environmental insults, cellular protein imbalance and targeted pharmaceuticals. Yet, mechanisms that cells deploy to counteract inhibition of this central regulator are little understood. To find such mechanisms, we reduced flux through the proteasome to the point of toxicity with specific inhibitors and performed genome-wide screens for mutations that allowed cells to survive. Counter to expectation, reducing expression of individual subunits of the proteasome's 19S regulatory complex increased survival. Strong 19S reduction was cytotoxic but modest reduction protected cells from inhibitors. Protection was accompanied by an increased ratio of 20S to 26S proteasomes, preservation of protein degradation capacity and reduced proteotoxic stress. While compromise of 19S function can have a fitness cost under basal conditions, it provided a powerful survival advantage when proteasome function was impaired. This means of rebalancing proteostasis is conserved from yeast to humans.